A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention

被引:51
|
作者
Patel, Hiten D. [1 ,2 ]
Riffon, Mark F. [1 ,2 ]
Joice, Gregory A. [1 ,2 ]
Johnson, Michael H. [1 ,2 ]
Chang, Peter [3 ]
Wagner, Andrew A. [3 ]
McKiernan, James M. [4 ]
Trock, Bruce J. [1 ,2 ]
Allaf, Mohamad E. [1 ,2 ]
Pierorazio, Phillip M. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA
[3] Beth Israel Deaconess Med Ctr, Div Urol, Boston, MA 02215 USA
[4] Columbia Univ, Med Ctr, Dept Urol, New York, NY USA
关键词
kidney neoplasms; carcinoma; renal cell; watchful waiting; early medical intervention; quality of life; NEPHRON-SPARING SURGERY; T1A KIDNEY CANCER; CELL CARCINOMA; RADICAL NEPHRECTOMY; HEALTH SURVEY; MANAGEMENT; OUTCOMES; TUMORS; SF-12; DIAGNOSIS;
D O I
10.1016/j.juro.2016.04.073
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To our knowledge quality of life has not been evaluated in rigorous fashion in patients undergoing active surveillance for small renal masses. The prospective, multi-institutional DISSRM (Delayed Intervention and Surveillance for Small Renal Masses) Registry was opened on January 1, 2009, enrolling patients with cT1a (4.0 cm or less) small renal masses who elected primary intervention or active surveillance. Materials and Methods: Patients were enrolled following a choice of active surveillance or primary intervention. The active surveillance protocol includes imaging every 4 to 6 months for 2 years and every 6 to 12 months thereafter. The SF12 (R) quality of life questionnaire was completed at study enrollment, at 6 and 12 months, and annually thereafter. MCS (Mental Component Summary), PCS (Physical Component Summary) and overall score were evaluated among the groups and with time using ANOVA and linear regression mixed modeling. Results: At 82 months among 3 institutions 539 patients were enrolled with a mean +/- SD followup of 1.8 +/- 1.7 years. Of the patients 254 were on active surveillance, 285 were on primary intervention and 21 were on active surveillance but crossed over to delayed intervention. A total of 1,497 questionnaires were completed. Total and PCS quality of life scores were better for primary intervention at enrollment through 5 years. There were generally no differences in MCS scores among the groups and there was a trend of improving scores with time. Conclusions: In a prospective registry of patients undergoing active surveillance or primary intervention for small renal masses those undergoing primary intervention had higher quality of life scores at baseline. This was due to a perceived benefit in the physical health domain, which persisted throughout followup. Mental health, which includes the domains of depression and anxiety, was not adversely affected while on active surveillance, and it improved with time after selecting a management strategy.
引用
收藏
页码:1356 / 1362
页数:7
相关论文
共 50 条
  • [1] Selecting Patients with Small Renal Masses for Active Surveillance: A Domain Based Score from a Prospective Cohort Study
    Sotimehin, Ayodeji E.
    Patel, Hiten D.
    Alam, Ridwan
    Gorin, Michael A.
    Johnson, Michael H.
    Chang, Peter
    Wagner, Andrew A.
    McKiernan, James M.
    Allaf, Mohamad E.
    Pierorazio, Phillip M.
    JOURNAL OF UROLOGY, 2019, 201 (05) : 886 - 891
  • [2] Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study
    Whelan, Emily A.
    Mason, Ross J.
    Himmelman, Jeffrey G.
    Matheson, Kara
    Rendon, Ricardo A.
    JOURNAL OF UROLOGY, 2019, 202 (01) : 57 - 61
  • [3] Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review
    Campi, Riccardo
    Sessa, Francesco
    Corti, Francesco
    Carrion, Diego M.
    Mari, Andrea
    Amparore, Daniele
    Mir, Maria C.
    Fiori, Cristian
    Papalia, Rocco
    Kutikov, Alexander
    Volpe, Alessandro
    Capitanio, Umberto
    Pierorazio, Phillip M.
    Scarpa, Roberto M.
    Porpiglia, Francesco
    Minervini, Andrea
    Serni, Sergio
    Esperto, Francesco
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (04) : 389 - 407
  • [4] Use of delayed intervention for small renal masses initially managed with active surveillance
    Gupta, Mohit
    Alam, Ridwan
    Patel, Hiten D.
    Semerjian, Alice
    Gorin, Michael A.
    Johnson, Michael H.
    Chang, Peter
    Wagner, Andrew A.
    McKiernan, James M.
    Allaf, Mohamad E.
    Pierorazio, Phillip M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (01) : 18 - 25
  • [5] Selecting Patients with Small Renal Masses for Active Surveillance
    Johnson, Michael H.
    Allaf, Mohamad E.
    Pierorazio, Phillip M.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 931 - 939
  • [6] Quality of Life and Psychological Distress among Patients with Small Renal Masses
    Vartolomei, Liliana
    Cotrus, Andrei
    Stanciu, Camelia
    Delcea, Cristian
    Tozzi, Marco
    Lievore, Elena
    Crocetto, Felice
    Del Giudice, Francesco
    Lucarelli, Giuseppe
    Muto, Matteo
    Ferro, Matteo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [7] Patients' perceptions on active surveillance for the treatment of small renal masses
    Charbonneau, Genevieve
    Hudon, Catherine
    Lavallee, Luke T.
    Kassouf, Wassim
    Gaboury, Isabelle
    Toren, Paul
    Couture, Felix
    Foley, Veronique
    Tetu, Amelie
    Richard, Patrick O.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) : 493.e17 - 493.e23
  • [8] Determinants of Active Surveillance in Patients With Small Renal Masses
    Nguyen, Kevin A.
    Nolte, Adam C.
    Alimi, Oriyomi
    Hsiang, Walter
    Lu, Amanda J.
    Ghabili, Kamyar
    Syed, Jamil S.
    Suarez-Sarmiento, Alfredo
    Perecman, Aaron J.
    Shuch, Brian
    Leapman, Michael S.
    UROLOGY, 2019, 123 : 167 - 173
  • [9] Conditional survival of patients with small renal masses undergoing active surveillance
    Petros, Firas G.
    Venkatesan, Aradhana M.
    Kaya, Diana
    Ng, Chaan S.
    Fellman, Bryan M.
    Karam, Jose A.
    Wood, Christopher G.
    Matin, Surena F.
    BJU INTERNATIONAL, 2019, 123 (03) : 447 - 455
  • [10] Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study
    Alam, Ridwan
    Patel, Hiten D.
    Osumah, Tijani
    Srivastava, Arnav
    Gorin, Michael A.
    Johnson, Michael H.
    Trock, Bruce J.
    Chang, Peter
    Wagner, Andrew A.
    McKiernan, James M.
    Allaf, Mohamad E.
    Pierorazio, Phillip M.
    BJU INTERNATIONAL, 2019, 123 (01) : 42 - 50